- Published at
- by manilatimes.net
mixed
mixed
News for Vifor Pharma AG (GNHAY)
- Published at
- by investing.com
positivepositiveCSL reports robust earnings growth, led by immunoglobulin sales By Investing.com
CSL reports robust earnings growth, led by immunoglobulin sales- Published at
- by seekingalpha.com
mixedmixed- Published at
- by prnewswire.com
mixedmixedIron Drugs Market size to grow by USD 3,552.86 million from 2022 to 2027: A growing number of CKD dialysis centers is an emerging trend - Technavio
/PRNewswire/ -- The iron drugs market size is forecast to increase by USD 3,552.86 million from 2022 to 2027, at a CAGR of 9.41%, according to the recent...- Published at
- by financialpost.com
mixedmixedCancellation of remaining publicly held registered shares of Vifor Pharma AG
Read latest breaking news, updates, and headlines. Financial Post offers information on latest national and international events & more.- Published at
- by globenewswire.com
mixedmixedSales of Intravenous Iron Drugs Market is Estimated to hit US$ 6.3 Bn at a CAGR of 8.5% by year 2032-end | Future Market Insights, Inc.
Ferric Carboxymaltose to Generate nearly 50% of the Intravenous Iron Drugs Market throughout the Analysis Period. The US market for Intravenous Iron Drugs...- Published at
- by insidermonkey.com
mixedmixed15 Biggest European Pharmaceutical Companies
Alongside the United States, Europe has some of the most advanced industries and economies in the world.- Published at
- by seekingalpha.com
positivepositiveCSL Limited: R&D Efforts And M&A Deal In The Limelight (OTCPK:CSLLY)
CSL's recent R&D investor briefing suggests that the company has been able to build a strong R&D pipeline. Find out why my rating for CSLLY stock now is a Buy.- Published at
- by financialpost.com
positivepositiveAustralia's CSL raises annual profit forecast on Swiss acquisition
SYDNEY — Australian biopharmaceutical company CSL Ltd raised its annual profit guidance by up to one-sixth as a result of its purchase of Swiss drugmaker Vifor…- Published at
- by marketscreener.com
positivepositiveApproval of delisting of Vifor Pharma AG's registered shares
SIX Exchange Regulation approves delisting of Vifor Pharma AG's registered shares The totality of the registered shares will be delisted following the legally binding court decision regarding the... | October 12, 2022- Published at
- by etfdailynews.com
positivepositiveVifor Pharma (OTCMKTS:GNHAY) Stock Price Down 7.7%
Read Vifor Pharma (OTCMKTS:GNHAY) Stock Price Down 7.7% at ETF Daily News- Published at
- by seekingalpha.com
positivepositiveCSL Limited Stock: Market's Focus Is On Guidance And Recent Acquisition (OTCMKTS:CSLLY)
Both the FY 2022 top line and bottom line for CSL didn't meet the market's expectations. Read what investors need to know about CSLLY here.- Published at
- by etfdailynews.com
positivepositiveVifor Pharma (OTCMKTS:GNHAY) Shares Up 6%
Read Vifor Pharma (OTCMKTS:GNHAY) Shares Up 6% at ETF Daily News- Published at
- by valueandopportunity.com
mixedmixedAll Swiss Shares Part 13 – Nr. 121-130
Back to Switzerland with 10 "fresh" and randomly selected Swiss stocks. This time, 5 of the 10 stocks might be worth to watch after a first analysis, although I need to slim down my watch list to a more manageable number at some point in time. Enjoy !! 121. VZ Holding VZ Holding is a…